Novel vaginal delivery systems for calcitonin: II. Preparation and characterization of HYAFF® microspheres containing calcitonin
- 1 January 1996
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 144 (1) , 19-26
- https://doi.org/10.1016/s0378-5173(96)04686-8
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Prevention of ovariectomy osteopenia in rats after vaginal administration of Hyaff 11 microspheres containing salmon calcitoninCalcified Tissue International, 1995
- Hyaluronic acid ester microspheres as a nasal delivery system for insulinJournal of Controlled Release, 1994
- Human neutrophil chemokinesis and polarization induced by hyaluronic acid derivativesBiomaterials, 1993
- Biodegradable poly(dl-lactic acid) formulations in a calcitonin delivery systemBiomaterials, 1993
- Intracolonic bioavailability of human calcitonin in manEuropean Journal of Clinical Pharmacology, 1992
- Hyaluronane derivative microspheres as NGF delivery devices: Preparation methods and in vitro release characterizationInternational Journal of Pharmaceutics, 1992
- Influence of the Mobile Phase on Salmon Calcitonin Analysis by Reversed-Phase Liquid ChromatographyJournal of Chromatographic Science, 1991
- Future horizons for calcitonin: A U.S. perspectiveCalcified Tissue International, 1991
- Microspheres of hyaluronic acid esters—Fabrication methods and in vitro hydrocortisone releaseJournal of Controlled Release, 1990
- The effect of rectal and nasal administration of salmon calcitonin in normal subjectsCalcified Tissue International, 1987